County of Harris, Texas v. Eli Lilly And Company, 4:19-cv-04994

Harris County, which operates a self-funded health plan and buys jail medications, sues major insulin manufacturers (Eli Lilly, Novo Nordisk, Sanofi) and PBMs (Express Scripts, CVS/Caremark, Aetna, Optum, etc.) alleging an "Insulin Pricing Scheme" that artificially inflated reported drug prices while secretly funneling rebates to PBMs.
County alleges the scheme caused millions in overcharges for diabetes medications (it alleges tens of millions spent overall), and that each purchase based on inflated prices is a separate DTPA injury; the largest single transaction alleged was under $1,800.
Harris County asserts violations of multiple DTPA subsections and a conspiracy to violate the DTPA; it pleads it is a "consumer" because it ‘‘seeks or acquires by purchase’’ pharmacy goods/services as a political subdivision.
Defendants moved to dismiss the DTPA claims arguing (1) the DTPA’s $500,000 large-transaction exemption applies (transactions should be aggregated into two projects), (2) the County is not a DTPA consumer because any benefit was incidental (employees were the consumers), and (3) the conspiracy claim fails if no underlying DTPA violation is plausibly alleged.
The court denied the motion: it found factual disputes (especially over defining a "project" and aggregation) requiring discovery, concluded it is plausible the County qualifies as a consumer (its benefit is not necessarily merely incidental), and therefore refused to dismiss the conspiracy claim.

Issue	Plaintiff's Argument	Defendant's Argument	Held
Whether DTPA §17.49(g) $500,000 exemption bars the County’s claims (aggregation/project rule)	Each insulin purchase is a separate transaction; no single project exceeds $500,000; transactional limit is an affirmative defense requiring proof	All purchases relate to two projects (health-plan subsidies and jail purchases) and must be aggregated, exceeding $500,000 and removing DTPA protection	Denied: resolution requires factual development; aggregation not appropriate to decide on 12(b)(6) from complaint alone
Whether Harris County is a "consumer" under the DTPA or merely an incidental beneficiary of employees’ purchases	County paid under its self-funded plan and directly suffered overcharges; benefits to County (healthy workforce) are an objective of transactions, so it qualifies as a consumer	Employees are the actual consumers; County’s benefit is derivative/incidental and not enough for DTPA standing	Denied: plausible that County’s benefit is more than incidental; consumer-status question requires discovery
Whether conspiracy-to-violate-DTPA claim survives absent an underlying DTPA violation	Underlying DTPA violations are plausibly alleged; conspiracy claim rests on those violations	Conspiracy claim fails if no viable underlying DTPA claim	Denied: because the court found plausible underlying DTPA claims, conspiracy claim survives

Bell Atl. Corp. v. Twombly, 550 U.S. 544 (plausibility standard for pleadings)
Wellborn v. Sears, Roebuck & Co., 970 F.2d 1420 (consumer status may extend to incidental/acquiring beneficiaries based on relationship to transaction)
Eckman v. Centennial Savs. Bank, 784 S.W.2d 672 (affirmative defenses under DTPA context and burden on defendant)
Villarreal v. Wells Fargo Bank, N.A., 814 F.3d 763 (DTPA consumer status: goods/services must be objective of transaction, not merely incidental)
Birchfield v. Texarkana Mem. Hosp., 747 S.W.2d 361 (consumer standing judged by relationship to transaction)
Kaiser Aluminum & Chem. Sales, Inc. v. Avondale Shipyards, Inc., 677 F.2d 1045 (on a 12(b)(6) motion court must accept complaint facts as true)